RBC Capital maintained Gilead Sciences (NASDAQ:GILD) $87 price target

By / / Gilead Sciences, Royal Bank of Canada

RBC Capital analyst Brian Abrahams reiterates Gilead Sciences (NASDAQ:GILD) with a Sector Perform and maintains $87 price target.

Scroll to Top